Meta-Analyses Do Not Establish Improved Mortality With Ivermectin Use in COVID-19
- PMID: 35389576
- DOI: 10.1097/MJT.0000000000001477
Meta-Analyses Do Not Establish Improved Mortality With Ivermectin Use in COVID-19
Conflict of interest statement
The authors have no conflicts of interest to declare.
Comment on
-
Re: "Commentary" by Rothrock et al. "Meta-Analyses Did Not Establish Improved Mortality With Ivermectin Use in COVID-19".Am J Ther. 2021 Dec 29;29(2):e233-e237. doi: 10.1097/MJT.0000000000001465. Am J Ther. 2021. PMID: 35389575 No abstract available.
References
-
- Bryant A, Lawrie TA, Fordham EJ, et al. Re: “Commentary” by Rothrock et al. “Meta-analyses did not establish improved mortality with ivermectin use in COVID-19.” Am J Ther. 2022;29. epub ahead of print. doi: 10.1097/MJT.0000000000001465. - DOI
-
- Bryant A, Lawrie T, Dowsell T, et al. Ivermectin for prevention and treatment of covid-19 (protocol). The evidence-based Medical Consultancy Ltd; 2021. Available at: https://tinyurl.com/cx7pnaxa. Accessed November 27, 2021.
-
- Rothrock SG, Weber KD, Giordano PA, et al. Meta-analyses do not establish improved mortality with ivermectin use in COVID-19. Am J Ther. 2021;29:e87–e94.
-
- CDC Health Alert Network. Rapid increase in ivermectin prescriptions and reports of severe illness associated with use of products containing ivermectin to prevent or treat COVID-19. Emergency preparedness and response. Centers for Disease Control and Prevention. Available at: https://emergency.cdc.gov/han/2021/han00449.asp. Accessed November 1, 2021.
-
- Temple C, Hoang R, Hendrickson RG. Toxic effects from ivermectin use associated with prevention and treatment of COVID-19. N Engl J Med. 2021;385:2197–2198.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical